ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Else Nutrition Holdings Inc

Else Nutrition Holdings Inc (BABY)

1.17
0.00
(0.00%)
Closed November 05 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.17
Bid
1.15
Ask
1.17
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.17
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
136,094,000
Dividend Yield
-
PE Ratio
-0.26
Earnings Per Share (EPS)
-0.11
Revenue
9.36M
Net Profit
-15.61M

About Else Nutrition Holdings Inc

Sector
Food Preparations, Nec
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
White Rock, British Columbia, Can
Founded
2019
Else Nutrition Holdings Inc is listed in the Food Preparations sector of the TSX Venture Exchange with ticker BABY. The last closing price for Else Nutrition was $1.17. Over the last year, Else Nutrition shares have traded in a share price range of $ 0.00 to $ 0.00.

Else Nutrition currently has 136,094,000 shares outstanding. The market capitalization of Else Nutrition is $159.23 million. Else Nutrition has a price to earnings ratio (PE ratio) of -0.26.

BABY Latest News

Else Nutrition Announces Up-Listing to the Toronto Stock Exchange

VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (β€œElse” or, the β€œCompany”) is pleased to announce that it has...

Else Establishes Its Own Manufacturing Capacity in Oregon U.S.A.

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children...

Sprouts Farmers Market Adds Else Kids Nutrition Products to its Retail Stores Across the U.S.

VANCOUVER, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Β ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children...

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing Canada NewsWire NEW YORK, Dec. 20, 2021 Individual and institutional investors as well as advisors are invited...

Early Warning Report filed pursuant to National Instrument 62-103

TEL AVIV, Israel, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Pursuant to National Instrument 62-103, The Early Warning System and Related Take-Over Bids and Insider Reporting Issues, Ms. Hamutal Yitzhak...

Else Nutrition Awarded Prestigious World Plant Based Award for 2021 in Best Dairy Product Alternative Category

VANCOUVER, British Columbia, Dec. 13, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children...

Else Nutrition to Participate in the Lytham Partners Winter 2021 Investor Conference

VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC.Β (TSX-V: BABY) (OTCQB: BABYF) (FSE: 0YL) (β€œElse” or the β€œCompany”),Β the plant-based baby, toddler and...

Else Nutrition Establishes North American Office in Columbus, Ohio, Behind Growth Plans

VANCOUVER, British Columbia, Dec. 06, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children...

Else Nutrition Reports Third Quarter 2021 Results

Hamutal Yitzhak, Else CEO, commented: β€œElse is a company that should not yet be measured solely by Quarters. We are building a pathway to be a potential global leader in the plant-based nutrition...

Independent Pilot Research Survey Demonstrates Else Products Dramatically Improved Major Feeding Related Disorders & Symptoms in Large Majority of Children

Independent pilot survey conducted among U.S. moms using Else Nutrition products with their children revealed dramatic improvement with up to complete recovery with feeding-related disorders and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAA.PFirst Tidal Acquisition Corp
$ 0.15
(200.00%)
9k
TVC.HThree Valley Copper Corp
$ 0.015
(200.00%)
2.66M
ALBT.PAlbatros Acquisition Corporation Inc
$ 0.02
(100.00%)
5k
IBOUniversal Ibogaine Inc
$ 0.01
(100.00%)
5.01k
ISGIInsuraguest Technologies Inc
$ 0.06
(100.00%)
10k
EPEmpire Metals Corp
$ 0.055
(-57.69%)
17k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
45.15k
EGTEguana Technologies Inc
$ 0.005
(-50.00%)
845k
PWROPower One Resources Corp
$ 0.025
(-37.50%)
348k
WAVEWaverley Pharma Inc
$ 0.01
(-33.33%)
95k
CCBCanada Carbon Inc
$ 0.015
(50.00%)
5.6M
TVC.HThree Valley Copper Corp
$ 0.015
(200.00%)
2.66M
PEXPacific Ridge Exploration Ltd
$ 0.03
(0.00%)
1.84M
SNMShaMaran Petroleum Corp
$ 0.085
(13.33%)
1.66M
ADYAdyton Resources Corp
$ 0.205
(10.81%)
1.62M

BABY Discussion

View Posts
chilar4567 chilar4567 2 hours ago
usually there is a PR indicating the next quarter report. All quiet from HQ.
PPS acting like belly up.

πŸ‘οΈ0
pual pual 6 days ago
I wonder if our dreaming CEO finally figured out she has to sell out before she and we have to write off our investment?
πŸ‘οΈ0
pual pual 6 days ago
I wonder if our dreaming CEO finally figured out she has to sell out before she and we have to write off our investment?
πŸ‘οΈ0
getyourownshares getyourownshares 2 weeks ago
Someone is buying heavy. Look at the capitulation
πŸ‘οΈ0
chilar4567 chilar4567 3 weeks ago
A buyer steps up to bat @ .03.
$0.030.00 (0.00%)
Bid x Size
$0.03 x 2,024,987
Ask x Size
$0.0403 x 10,000
Real Time Equity Quote: Oct 14, 2024, 9:30 AM ET
πŸ‘οΈ0
luigidt luigidt 1 month ago
there is no submission - FDA does not approve infant formula - they just set basic requirements
πŸ‘οΈ0
pual pual 1 month ago
Anyone knows where we stand relative to our submission(s) to the FDA?
πŸ‘οΈ0
Harbor6460 Harbor6460 1 month ago
This is either a RS or trips before year end
πŸ‘οΈ0
pual pual 1 month ago
Could be but I think she finances herself by increasing the number of O\S
πŸ‘οΈ0
bar1080 bar1080 1 month ago
How about a current honest value on The liabilities? The Debt? $Thousands? $Millions ???????? More?

Without an audit, I'd assume the numbers are really ugly
πŸ‘οΈ0
pual pual 1 month ago
Our incompetent CEO is in panic and to stupid to look for help from a business type person. She enjoys a board made of scientifics discussing scientific subjects. for more than 3 years she did nothing to try to understand why the value of her company went down the drain. What a crazy dreamer !!!
πŸ‘οΈ0
bar1080 bar1080 1 month ago
Why no recent audits??? How hard would it be to put a current honest value on almonds, buckwheat and tapioca?

"When was the last time BABYF released audited numbers?"
πŸ‘οΈ0
pual pual 2 months ago
Another way to do it. Good luck.
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
pual,
I've increased (at these current low prices)with intention of taking losses by year end.
Just selling on FIFO basis should provide the losses you desire.
πŸ‘οΈ0
pual pual 2 months ago
I hope our CEO has now figured out that developing new products and\or adding shelves where to store our inventories is not really the objectives she should pursue.
I start to believe that if she doesn’t sell out her company and register rights we will have to write off our investment and include our loss as a tax deduction. At current price, I may sell out by year end, take my capital loss as a tax deduction (in Canada and Quebec) and buy back, just in case … who knows.
πŸ‘οΈ0
pual pual 2 months ago
FDA approval has been waited for for almost 2 years and now the taste is another issue. Add that to the leadership of an incompetent CEO who doesn't know how to address these issues. As any incompetent business person facing such issues, our CEO think that cutting the expenses is a solution ... when it is generally another problem ... What a mess!
πŸ‘οΈ0
BruceLake BruceLake 2 months ago
The whole "problem" could also be that their products taste like crap. Bought a container of their complete shake mix a few years ago and the only way my grandson would drink it is if I also put in a banana, regular milk and a few other ingredients. Defeats the purpose of paying a premium price for a plant-based mix. Never finished it so there's no way I was going to order it again. I'm really glad I sold all my shares (except 5000 in a forgotten account) about two years ago.
👍️ 1
BruceLake BruceLake 2 months ago
The whole "problem" could also be that their products taste like crap. Bought a container of their complete shake mix a few years ago and the only way my grandson would drink it is if I also put in a banana, regular milk and a few other ingredients. Defeats the purpose of paying a premium price for a plant-based mix. Never finished it so there's no way I was going to order it again. I'm really glad I sold all my shares (except 5000 in a forgotten account) about two years ago.
πŸ‘οΈ0
Justaroundthecorner Justaroundthecorner 2 months ago
So..
How does the FDA oversee the safety and nutritional quality of infant formula??
Infant formula is a food that may be the sole source of nutrition for infants (i.e., children up to 12 months of age) as an alternative to human milk. The FDA regulatory requirements address, among other issues, the safety, nutritional adequacy, packaging, and labeling of these products. The FDA does not approve infant formulas; however, infant formula manufacturers must notify the agency before marketing a new formula. The FDA’s highly trained staff review these notifications to make sure new formulas meet federal nutrition, labeling, and other requirements. If a product does not meet applicable requirements, the formula may be deemed adulterated, misbranded, or both, and the FDA has the authority to take enforcement action. For example, the FDA can require a mandatory recall of product if the agency determines that an adulterated or misbranded infant formula presents a risk to human health.

Among the requirements for infant formulas, the FDA specifies 30 nutrients that must be included in infant formulas. There are minimum amounts for all 30 nutrients and maximum amounts for 10 nutrients. In addition, any ingredient used in infant formula must be safe and suitable for such use. Additionally, sanitary controls are required by law to prevent contamination and other safety problems from occurring. For example, manufacturers must establish a system of controls designed to ensure that infant formula does not become adulterated due to the presence of microorganisms in the formula or in the processing environment. Further, the FDA regulations set forth certain testing requirements of finished product for Salmonella and Cronobacter. FDA regulations also require that the water the companies use to manufacture formulas meets safety standards set by the U.S. Environmental Protection Agency.

The FDA has specific requirements for labeling infant formulas. Information that is most helpful for caregivers of infants includes directions for preparation and use, and a pictogram showing the major steps for preparing infant formula, a β€œuse by” date.

The FDA inspects facilities that manufacture infant formulas annually and carefully trains its investigators to ensure that every infant formula inspection is robust, thorough, and focused on the most critical aspects of the infant formula manufacturing process.

All Infant formula products sold in the U.S., whether produced domestically or imported, must meet all U.S. requirements, including those for safety and nutritional adequacy. Caregivers should use caution when ordering imported products online or from third party distributors because some of these products have not undergone FDA's rigorous premarket review process and do not meet U.S. requirements for safety or nutritional adequacy.

....
πŸ‘οΈ0
bar1080 bar1080 2 months ago
When was the last time BABYF released audited numbers?
πŸ‘οΈ0
pual pual 2 months ago
The whole problem is MARKETING (Our CEO thinks it's a useless EXPENSE) and therefore dismal revenues.
People do not know about us nor do they about our offerings.
Our CEO only talk to shareholders and the topics (except for mandatory filings) always relates to additional products she developped and shelves she added. That means additional costs. We have more and more products sitting on shelves (inventories) and more and more shelves to put them on.
Bottom line:
- minimal revenues (she doesn't know how to grow,
- growing expenses she tries to reduce (she doesn't know the difference between ''expense'' and ''investment''). She believe marketing to be an expense.
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
JP, ET is around $4.00, but I guess $50 would be ok if you but 100K.
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
not convs but lot of warrants. I don't think they are tradeable.
πŸ‘οΈ0
jpike jpike 2 months ago
Schwab charges $50 commission on foreign transactions. First I knew of that.
πŸ‘οΈ0
jpike jpike 2 months ago
Are part of the problem convertibles?
πŸ‘οΈ0
pual pual 2 months ago
Our downfall has nothing to do with what the market does. The market went thru the roof for the last 3 years and BABYF went down the drain all along.
OUR PROBLEM IS OUR DUMB CEO!
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
JP, crap shot here. Know the extent of loss if Baby goes belly up and take a shot.
πŸ‘οΈ0
jpike jpike 2 months ago
Stocks market this Sept was the worst in 23 years.
πŸ‘οΈ0
pual pual 2 months ago
(CAD) Jun 2024 Y/Y
Revenue 2.63M
Net income -2.52M
And the boss keeps cutting expenses, adding shelves (inventories) and not doing any marketing investment. Hard to find a more incompetent CEO.
πŸ‘οΈ0
pual pual 2 months ago
That could be except for ''surprise sales increase''. As for FDA approval (assuming it is still possible) it would change nothing unless our stubborn CEO also decide to invest in marketing.
πŸ‘οΈ0
pual pual 2 months ago
If our CEO keep making a fool of herself, you may very well be right.
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
Harbor, perhaps! However we just might have (temporarily) bottomed out the last few days.
KIM prior to your prediction arriving at fruition, good things could happen: Buy out offer, FDA approval, Mgmt making bid to go private, surprise sales increase.
πŸ‘οΈ0
Harbor6460 Harbor6460 2 months ago
Its over gere. A RS or bankrupt in 6 months
πŸ‘οΈ0
pual pual 2 months ago
And the woman stays silent, most likely in her lab working at developping a new product. How stupid can someone be !!!
πŸ‘οΈ0
jpike jpike 2 months ago
I would rather buy at these prices than sell. BUY LOW and this is lowest.
πŸ‘οΈ0
bar1080 bar1080 2 months ago
Again, I don't own this obvious piece of junk. Never did. And pennyland patents never have real value.

Gee, a mix of almonds, buckwheat, and tapioca.
πŸ‘οΈ0
pual pual 2 months ago
Maybe but i hope that someone will fet to our CEO and make her understand that she baddly needs help. Right now our market value is less than $10,000,000 or our yearly gross revenue. Even her may figure out that she is digging her own (and our) grave ???
πŸ‘οΈ0
pual pual 2 months ago
Unless you believe that there must be a limit to the stupidity of the CEO. There is a lot of value in this company and the issue is not with the offering but with the way management doesn't talk to the market.
This being said, I agree that averaging down is generally quite a bad idea.
πŸ‘οΈ0
longview1 longview1 2 months ago
Turning into a micro penny soon
πŸ‘οΈ0
bar1080 bar1080 2 months ago
Nothing's dumber than averaging down on a failing (failed) penny stock.
πŸ‘οΈ0
pual pual 2 months ago
Absolutely. As you suggest, one should however just bet money he can afford.
πŸ‘οΈ0
pual pual 2 months ago
I did average down at $0,06 and may do it again. I just cannot believe that our CEO will be more stupid that I even think she is. She must to somehow find a little sanity and figure out she needs help or sell out altogether ???
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
I keep telling myself they aren't going belly up, and think the patents have value..
So the answer is yes in moderation. I know how much I'll lose @ 0 and can live with it.
Or, guess should have said, live without it.
πŸ‘οΈ0
jpike jpike 2 months ago
IS THIS THWE BEST TIME EVER TO BUY AND ACCUMULATE?
πŸ‘οΈ0
pual pual 2 months ago
Good suggestion but there is multiple ways to market our product. This being said, i believe that our CEO left her previous employment, frustrated to see the company invest in marketing instead of product development. She then decided to create this company aimed at developping products that she not only doesn't understand how to market them but is totally reluctant to SPEND any money trying to do any kind of marketing (She believe that INVESTING in marketing is a useless EXPENSE.
She will prefer to fail (she is off a good start) instead of admitting she is totally ridiculous putting inventories on shelves, expecting that it will sell by itself.
If she had good partners around her (such as BOD members) she maybe could be educated somewhat but she created a board made of scientific people most likely not qualified to help her understand ... unless she is even more stubborn than i tought ???
πŸ‘οΈ0
luigidt luigidt 2 months ago
and the best and cheapest way to do that is one is online marketing! brick and mortar is not the path to follow - only one that would have made sense besides Walmart is Costco
πŸ‘οΈ0
pual pual 2 months ago
Putting products no one knows about on shelves is close to spreading an inventory all over the place.
THE THING TO DO: Tell the people what we are all about and how our offer can benefit to them is MANDATORY. Our scientific CEO doesn't understand that and is so stubborn that she still believe after 5 years that people do buy product they do not know about.
WHAT WILL IT TAKE FOR HER TO FIGURE OUT SHE IS GONNA FAIL IF SHE KEEPS ACTING STUPID?
πŸ‘οΈ0
longview1 longview1 2 months ago
It was on the shelves but don’t know about now. This was when stock was around 2-3 dollars a share.
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
A decent bid shows up:
Bid x Size
$0.043 x 339,555
Ask x Size
$0.045 x 50,000
Real Time Equity Quote: Aug 29, 2024, 12:20 PM ETinfo_outline
πŸ‘οΈ0
chilar4567 chilar4567 2 months ago
LV, I dk if we are on shelves or just @ Walmart
on line. I seem to recall on line was mentioned.
I'll drop in for a quick check & see.
πŸ‘οΈ0